 |
doxorubicin |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2009-08-25 00:00:00 |
| Sponsor | Delcath Systems, Inc.;1633 Broadway, Suite 22C;New York, New York, 10019 |
| |
doxorubicin |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2009-08-25 00:00:00 |
| Sponsor | Delcath Systems, Inc.;1633 Broadway, Suite 22C;New York, New York, 10019 |